RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Evangeline Motley-Johnson to Lysophosphatidylcholines

This is a "connection" page, showing publications Evangeline Motley-Johnson has written about Lysophosphatidylcholines.
  1. Motley ED, Kabir SM, Gardner CD, Eguchi K, Frank GD, Kuroki T, Ohba M, Yamakawa T, Eguchi S. Lysophosphatidylcholine inhibits insulin-induced Akt activation through protein kinase C-alpha in vascular smooth muscle cells. Hypertension. 2002 Feb; 39(2 Pt 2):508-12.
    View in: PubMed
    Score: 0.206
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support